ATE254452T1 - Verfahren zur verbesserung der fertilisierenden aktivität von spermatozoa - Google Patents

Verfahren zur verbesserung der fertilisierenden aktivität von spermatozoa

Info

Publication number
ATE254452T1
ATE254452T1 AT00947995T AT00947995T ATE254452T1 AT E254452 T1 ATE254452 T1 AT E254452T1 AT 00947995 T AT00947995 T AT 00947995T AT 00947995 T AT00947995 T AT 00947995T AT E254452 T1 ATE254452 T1 AT E254452T1
Authority
AT
Austria
Prior art keywords
spermatozoa
improving
fertilizing activity
fertilizing
activity
Prior art date
Application number
AT00947995T
Other languages
English (en)
Inventor
Michaela Luconi
Elisabetta Baldi
Gianni Forti
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE254452T1 publication Critical patent/ATE254452T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Fertilizers (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00947995T 1999-07-26 2000-07-25 Verfahren zur verbesserung der fertilisierenden aktivität von spermatozoa ATE254452T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999FI000171A IT1307787B1 (it) 1999-07-26 1999-07-26 Processo per incrementare la motilita' degli spermatozoi e spermatozoia motilita' superiore cosi' ottenuti.
PCT/EP2000/007108 WO2001007021A2 (en) 1999-07-26 2000-07-25 Process for the improvement of spermatozoa fertilization activity

Publications (1)

Publication Number Publication Date
ATE254452T1 true ATE254452T1 (de) 2003-12-15

Family

ID=11353050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947995T ATE254452T1 (de) 1999-07-26 2000-07-25 Verfahren zur verbesserung der fertilisierenden aktivität von spermatozoa

Country Status (12)

Country Link
EP (2) EP1380304A3 (de)
JP (1) JP2003505412A (de)
AT (1) ATE254452T1 (de)
AU (1) AU777618B2 (de)
CA (1) CA2378650A1 (de)
DE (1) DE60006675T2 (de)
DK (1) DK1196153T3 (de)
ES (1) ES2206276T3 (de)
IL (1) IL147676A0 (de)
IT (1) IT1307787B1 (de)
PT (1) PT1196153E (de)
WO (1) WO2001007021A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2264427B1 (de) 1997-01-31 2017-05-03 Xy, Llc Optisches Gerät mit fokussierendem Reflektor zur Konvergenz der Strahlung auf einen Partikelfluss, und zugehöriges Analyseverfahren
US6071689A (en) 1997-12-31 2000-06-06 Xy, Inc. System for improving yield of sexed embryos in mammals
US6149867A (en) 1997-12-31 2000-11-21 Xy, Inc. Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
US7208265B1 (en) 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
US7713687B2 (en) 2000-11-29 2010-05-11 Xy, Inc. System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
WO2002043486A1 (en) 2000-11-29 2002-06-06 Xy, Inc. System for in-vitro fertilization with spermatozoa separated into x-chromosome and y-chromosome bearing populations
AU2003255529B2 (en) * 2002-07-10 2008-11-20 Laboratoires Serono Sa Use of compounds for increasing spermatozoa motility
JP4595067B2 (ja) 2002-08-01 2010-12-08 エックスワイ，エルエルシー 低圧精子細胞分離システム
US8486618B2 (en) 2002-08-01 2013-07-16 Xy, Llc Heterogeneous inseminate system
CA2534394C (en) 2002-08-15 2013-01-08 Xy, Inc. High resolution flow cytometer
US7169548B2 (en) 2002-09-13 2007-01-30 Xy, Inc. Sperm cell processing and preservation systems
BRPI0408857B1 (pt) 2003-03-28 2018-09-11 Inguran Llc aparelho, métodos e processos para separar partículas e para prover esperma de animal separado por sexo
ES2541121T3 (es) 2003-05-15 2015-07-16 Xy, Llc Clasificación eficiente de células haploides por sistemas de citometría de flujo
DK2801363T3 (en) 2004-03-29 2018-05-28 Inguran Llc PROCEDURE FOR STORING SORTED SPERMATOZOES
CA2574499C (en) 2004-07-22 2016-11-29 Monsanto Technology Llc Process for enriching a population of sperm cells
EP1726297B1 (de) * 2005-05-23 2010-08-18 Reckitt Benckiser (UK) Limited Zusammensetzung enthalend Wortmannin und ihre topische Verwendung zur Haarwuchshemmung
TR201819543T4 (tr) * 2011-05-20 2019-01-21 Brigham & Womens Hospital Inc Hareketli hücrelerin analizi ve ayıklanması.
US11549098B2 (en) * 2012-03-16 2023-01-10 Fertility Innovations Limited Processing of sperm cells
PT110231B (pt) * 2017-08-02 2021-02-22 Universidade Do Porto Potenciadores de mtor e suas utilizações para melhorar a qualidade e função do esperma durante o armazenamento
US10603075B1 (en) 2018-11-30 2020-03-31 Ohana Biosciences, Inc. Compositions and methods for enhancing sperm function

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774088A (en) * 1986-01-08 1988-09-27 The United States Of America As Represented By The Deptment Of Health And Human Services Method and additives for improving the quality and shelf life of stored blood
KR920002285B1 (ko) * 1989-10-19 1992-03-21 태평양화학 주식회사 세포 보호제
HUT69991A (en) * 1992-03-09 1995-09-28 Univ Washington Methods for the regulation of plant fertility
US6632789B1 (en) * 1994-04-29 2003-10-14 The United States Of America As Represented By The Secretary Of The Navy Methods for modulating T cell responses by manipulating intracellular signal transduction
JP2991620B2 (ja) * 1994-08-30 1999-12-20 科学技術振興事業団 細胞活動の制御方法
JP2000345724A (ja) * 1999-06-03 2000-12-12 Masafumi Miyamoto アミューズメント施設、アミューズメント施設用コンテナ及びアミューズメント設備の設置方法

Also Published As

Publication number Publication date
WO2001007021A2 (en) 2001-02-01
WO2001007021A3 (en) 2001-12-06
PT1196153E (pt) 2004-02-27
IT1307787B1 (it) 2001-11-19
EP1380304A3 (de) 2004-07-07
EP1380304A2 (de) 2004-01-14
EP1196153B1 (de) 2003-11-19
AU6159700A (en) 2001-02-13
DK1196153T3 (da) 2004-01-05
IL147676A0 (en) 2002-08-14
JP2003505412A (ja) 2003-02-12
EP1196153A2 (de) 2002-04-17
DE60006675D1 (de) 2003-12-24
AU777618B2 (en) 2004-10-21
ES2206276T3 (es) 2004-05-16
ITFI990171A0 (it) 1999-07-26
CA2378650A1 (en) 2001-02-01
ITFI990171A1 (it) 2001-01-26
DE60006675T2 (de) 2004-09-30

Similar Documents

Publication Publication Date Title
ATE254452T1 (de) Verfahren zur verbesserung der fertilisierenden aktivität von spermatozoa
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
DE69833134D1 (de) Verwendung aliphatischer amine zur verminderung von oxalat
DE69910368D1 (de) Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
EP0652749A4 (de) Verfahren und Zusammensetzungen zur Hemmung der 5 Alpha - Reduktase Aktivität.
ATE384732T1 (de) Vegi, ein inhibitor der angiogenese und des tumorwachstums
DE60027405D1 (de) Verfahren zur steigerung der aktivität von haustieren
DE69941800D1 (de) Salze von Liponsaürederivaten und deren Verwendung bei der Behandlung von Krankheiten
DE69724855D1 (de) Verfahren, Datenspeicher und System zur automatischen Veränderung von objektorientierten Computerprogrammen, welche Zugriff und Veränderung von persistent gespeicherten Objekten aufweisen.
DE69328497D1 (de) Verfahren zur steigerung der wirksamkeit der futterverwertung bei tieren
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE3880118D1 (de) Verwendung eines mittels in form von mikrokapseln zur schabenbekaempfung.
DK0986382T3 (da) RAF-kinasehæmmere
ATE287402T1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
DE69432859D1 (de) Verfahren zur reinigung von kollagenase
ATE312603T1 (de) Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren
DE69207521D1 (de) Senkrecht zur Oberfläche emittierender Halbleiterlaser und Verfahren zu seiner Herstellung
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
DE59712415D1 (de) Verfahren zur amplifikation von nukleinsäure
NO881892D0 (no) Nitrifikasjonshemmende middel.
DE69818698D1 (de) Inhibitoren von metalloproteinasen, ihre therapeutische verwendung und verfahren zur herstellung der grundstoffe für ihre synthese
DE50103394D1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten
DE69630969T2 (de) Verfahren zur hemmung des plasminogen-aktivator-inhibitors
DE60118367D1 (de) Verfahren zur fluormethylierung von alkoholen
ATE362993T1 (de) Verfahren zur entwicklung von pdk1-modulatoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1196153

Country of ref document: EP

REN Ceased due to non-payment of the annual fee